Public Profile

Gedeon Richter

Gedeon Richter Plc, commonly referred to as Richter, is a prominent global pharmaceutical company headquartered in Hungary (HU). Founded in 1901, the company has established a strong presence in various operational regions, including Europe, Asia, and North America. Specialising in women's health, central nervous system disorders, and generic pharmaceuticals, Richter is renowned for its innovative approach to drug development. The company’s core products include hormonal contraceptives and treatments for infertility, which are distinguished by their high quality and efficacy. Over the years, Gedeon Richter has achieved significant milestones, including strategic partnerships and a robust pipeline of new therapies. With a commitment to research and development, Richter has solidified its position as a key player in the global pharmaceutical market, recognised for its contributions to healthcare and patient well-being.

DitchCarbon Score

How does Gedeon Richter's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

64

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Gedeon Richter's score of 64 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.

81%

Let us know if this data was useful to you

Gedeon Richter's reported carbon emissions

In 2024, Gedeon Richter reported total carbon emissions of approximately 324,127,000 kg CO2e. This figure includes Scope 1 emissions of about 45,632,000 kg CO2e, Scope 2 emissions of approximately 91,724,000 kg CO2e (market-based), and Scope 3 emissions of around 186,771,000 kg CO2e. In 2023, their global emissions were about 336,516,000 kg CO2e, with Scope 1 at 53,104,000 kg CO2e, Scope 2 at approximately 103,252,000 kg CO2e (market-based), and Scope 3 at around 180,160,000 kg CO2e. Gedeon Richter has set ambitious climate commitments, aiming for a 55% reduction in greenhouse gas emissions across all scopes by 2030, starting from a 2020 baseline. Additionally, they plan to reduce Scope 1 and Scope 2 emissions by 30% by 2030. Notably, they aim to bring Scope 1 and Scope 2 emissions close to zero by 2025. In Hungary, the company reported emissions of about 197,000,000 kg CO2e in 2023 and approximately 213,000,000 kg CO2e in 2022, although specific scope breakdowns for these figures were not disclosed. Gedeon Richter's ongoing efforts reflect a commitment to sustainability and a proactive approach to mitigating climate impact.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

201820202021202220232024
Scope 1
37,359,000
00,000,000
00,000,000
00,000,000
00,000,000
00,000,000
Scope 2
73,452,000
00,000,000
00,000,000
00,000,000
000,000,000
00,000,000
Scope 3
104,973,000
000,000,000
000,000,000
000,000,000
000,000,000
000,000,000

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Gedeon Richter's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Gedeon Richter is in HU, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Gedeon Richter is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

STADA Arzneimittel Aktiengesellschaft

DE
Pharmaceutical Preparation Manufacturing
Updated 24 minutes ago

Aspen Pharmacare

ZA
Pharmaceutical Preparation Manufacturing
Updated 24 minutes ago

Indies Pharma Jamaica Limited

JM
Pharmaceutical Preparation Manufacturing
Updated 24 minutes ago

Bausch Health Cos

CA
Pharmaceutical Preparation Manufacturing
Updated 24 minutes ago

Teva Pharmaceuticals

IL
Pharmaceutical Preparation Manufacturing
Updated 24 minutes ago

Sandoz S.R.L.

RO
Pharmaceutical Preparation Manufacturing
Updated 24 minutes ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers